Bank Vontobel AG Share Price

Certificat

RMAYCV

CH1235104564

Market Closed - Swiss Exchange 08:50:01 12/06/2024 pm IST
100.8 CHF +0.10% Intraday chart for Bank Vontobel AG
Current month+0.30%
3 months+0.60%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMAYCV
ISINCH1235104564
Date issued 08/03/2023
Strike 265.7 CHF
Maturity 10/03/2025 (255 Days)
Parity 0.27 : 1
Emission price 99 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101.6 CHF
Lowest since issue 97.9 CHF

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAYCV Certificat